Verano Holdings (VRNO) Accumulated Expenses (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Accumulated Expenses of $55.5 million for Q1 2026, down 5.08% year-over-year from $58.5 million in Q1 2025, and down 19.93% quarter-over-quarter from $69.3 million in Q4 2025.
Verano Holdings (VRNO) Accumulated Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Accumulated Expenses for 6 consecutive years, with $55.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 5.08% year-over-year to $55.5 million; the TTM figure through Mar 2026 stood at $55.5 million (down 5.08% YoY), while the FY2025 annual figure was $69.3 million, up 0.52% from the prior year.
- Accumulated Expenses fell to $55.5 million in Q1 2026 per VRNO's latest filing, from $69.3 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $71.8 million in Q3 2025 and bottomed at $30.8 million in Q2 2022.
- Historically, Accumulated Expenses has averaged $56.1 million across 5 years, with a median of $59.9 million in 2024.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 74.43% — and 2025, when it slipped 6.49%.
- Verano Holdings' Accumulated Expenses stood at $41.8 million in 2022, then surged by 59.87% to $66.8 million in 2023, then rose by 3.26% to $68.9 million in 2024, then increased by 0.52% to $69.3 million in 2025, then declined by 19.93% to $55.5 million in 2026.
- Business Quant data shows VRNO's Accumulated Expenses at $55.5 million in Q1 2026, $69.3 million in Q4 2025, and $71.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.69 Mn |
| Mar 31, 2026 | 55.49 Mn |
| Dec 31, 2025 | 69.30 Mn |
| Sep 30, 2025 | 71.76 Mn |
| Jun 30, 2025 | 61.51 Mn |
| Mar 31, 2025 | 58.46 Mn |
| Dec 31, 2024 | 68.94 Mn |
| Sep 30, 2024 | 69.92 Mn |
| Jun 30, 2024 | 65.78 Mn |
| Mar 31, 2024 | 61.30 Mn |
| Dec 31, 2023 | 66.77 Mn |
| Sep 30, 2023 | 52.11 Mn |
| Jun 30, 2023 | 53.68 Mn |
| Mar 31, 2023 | 37.91 Mn |
| Dec 31, 2022 | 41.76 Mn |
| Sep 30, 2022 | 32.05 Mn |
| Jun 30, 2022 | 30.77 Mn |
| Dec 31, 2021 | 42.15 Mn |